Matches in Wikidata for { <http://www.wikidata.org/entity/Q96115159> ?p ?o ?g. }
- Q96115159 description "article scientifique publié en 2020" @default.
- Q96115159 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96115159 description "im Juni 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q96115159 description "scientific article published on 04 June 2020" @default.
- Q96115159 description "wetenschappelijk artikel" @default.
- Q96115159 description "наукова стаття, опублікована 4 червня 2020" @default.
- Q96115159 name "Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher-risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic Syndromes" @default.
- Q96115159 name "Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher-risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic Syndromes" @default.
- Q96115159 type Item @default.
- Q96115159 label "Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher-risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic Syndromes" @default.
- Q96115159 label "Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher-risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic Syndromes" @default.
- Q96115159 prefLabel "Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher-risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic Syndromes" @default.
- Q96115159 prefLabel "Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher-risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic Syndromes" @default.
- Q96115159 P1433 Q96115159-7BAFE259-75F1-4673-804E-332F069CAE1F @default.
- Q96115159 P1476 Q96115159-146F0FE5-0CB1-4D88-95F3-20E39E62E4C2 @default.
- Q96115159 P2093 Q96115159-4F3480D1-88D9-4B4B-BC19-47C11F11DAFB @default.
- Q96115159 P2093 Q96115159-5BE8709E-23FD-449E-9DE7-F37DCBF3D950 @default.
- Q96115159 P2093 Q96115159-68380519-10E6-4E7F-9C66-13D370812CB2 @default.
- Q96115159 P2093 Q96115159-6C4881C9-883B-4982-9DC0-2B71FEBAC2F4 @default.
- Q96115159 P2093 Q96115159-7101E671-97E8-4AC2-A33F-64161207E46E @default.
- Q96115159 P2093 Q96115159-7A3D6822-6905-4F7D-9C5E-DD342B69D19F @default.
- Q96115159 P2093 Q96115159-87B96EB8-4619-474E-8051-F5F7A270DA4D @default.
- Q96115159 P2093 Q96115159-A36E9A7F-078D-45C3-BFE3-FAA93245038E @default.
- Q96115159 P2093 Q96115159-ADBFA5DA-7F9F-4E15-9151-378CDCC27E20 @default.
- Q96115159 P2093 Q96115159-B768EDD4-0EAB-4838-BFC9-D527A7E80D83 @default.
- Q96115159 P2093 Q96115159-BCF16BB0-EDD2-4682-A64F-543FAF21D179 @default.
- Q96115159 P2093 Q96115159-C7F48A9E-5689-48B6-B518-EE70ECE38961 @default.
- Q96115159 P2093 Q96115159-CAD6A83E-0592-43F3-9C24-23EE49206B0C @default.
- Q96115159 P2093 Q96115159-D1E879E9-5C26-4417-9B16-000D24D411EF @default.
- Q96115159 P2093 Q96115159-DB9E5248-1520-47C0-B5C4-BF7BFA742D43 @default.
- Q96115159 P2093 Q96115159-E4103035-4592-4A8A-B9F1-B7B3B55AA463 @default.
- Q96115159 P2093 Q96115159-E79911B5-6C8E-4E26-83F6-F1684D93E0C0 @default.
- Q96115159 P2093 Q96115159-EE0F757D-22E0-4D62-A1CF-21FA11E56DA4 @default.
- Q96115159 P2860 Q96115159-0AAA0F9B-6391-4EA7-A07D-ABDA251F0906 @default.
- Q96115159 P2860 Q96115159-0B4DCBB8-8895-47ED-B5B0-2B1F915E7ACE @default.
- Q96115159 P2860 Q96115159-19F7D385-1470-47ED-B9FB-51FDC9C615A0 @default.
- Q96115159 P2860 Q96115159-1AC43BC5-6975-48A1-A637-F3E8E2934D10 @default.
- Q96115159 P2860 Q96115159-1BC816B2-EE55-452F-92D3-D6F22DA241BB @default.
- Q96115159 P2860 Q96115159-1CB5C912-BE15-4A84-AED9-47D2655E4C0B @default.
- Q96115159 P2860 Q96115159-1EC11228-EDA8-4BFC-BE7E-0878D407EDE6 @default.
- Q96115159 P2860 Q96115159-28FBE00E-4F09-411F-8B38-D7F44FA97515 @default.
- Q96115159 P2860 Q96115159-2CB52619-C206-4B9E-AAE6-82433EA0F234 @default.
- Q96115159 P2860 Q96115159-4916B1CD-B0B0-4E63-9C8E-CA565872C140 @default.
- Q96115159 P2860 Q96115159-4F68E533-E339-48AD-983B-A221CB627FF6 @default.
- Q96115159 P2860 Q96115159-5804B878-40C7-4B55-B5F5-52E9E0357B55 @default.
- Q96115159 P2860 Q96115159-70EB47F9-58E2-4B2E-BED9-7D004D85BC89 @default.
- Q96115159 P2860 Q96115159-73C92484-3CD6-4C23-8C2C-725A18E2013F @default.
- Q96115159 P2860 Q96115159-76A96061-EFB8-4485-8AD1-AAB85FE095DC @default.
- Q96115159 P2860 Q96115159-7BAB49F1-4C46-439D-A6F1-E79ECE978275 @default.
- Q96115159 P2860 Q96115159-7C44F510-EE0C-499D-83E6-65ED7FE60823 @default.
- Q96115159 P2860 Q96115159-8E946765-F33E-4293-B48A-6EB665CA5866 @default.
- Q96115159 P2860 Q96115159-9674F28A-B5D2-4A4C-A5CE-B2C634135157 @default.
- Q96115159 P2860 Q96115159-9A2F7C82-97CD-4E94-9027-C8C691964730 @default.
- Q96115159 P2860 Q96115159-A0CDCFFB-C98E-4BE8-B5D8-BA83D18CEC2B @default.
- Q96115159 P2860 Q96115159-B0F41E71-6A35-4669-BF8E-2CA5726A57F8 @default.
- Q96115159 P2860 Q96115159-B896A3CA-E1AD-46B6-A9C1-BD20C61A4E2C @default.
- Q96115159 P2860 Q96115159-C899CC2C-B4C6-4AAB-8C7E-8B94C80DF1F9 @default.
- Q96115159 P2860 Q96115159-CD2BF3F8-4B24-4CB0-8B1F-252ED33155AC @default.
- Q96115159 P2860 Q96115159-D7A59FF6-8CE2-4699-8A2C-8D19F3F74056 @default.
- Q96115159 P2860 Q96115159-D7C39FBA-68A0-4449-89D3-603F8384FBFA @default.
- Q96115159 P2860 Q96115159-DF1484CA-3D86-4D27-B186-327FB8E2EC30 @default.
- Q96115159 P2860 Q96115159-F10E1829-CB62-4024-83C6-D8923C9C95CB @default.
- Q96115159 P2860 Q96115159-FC556845-4147-4416-B211-44805F7D40D4 @default.
- Q96115159 P31 Q96115159-0DF3C4E9-B3C0-4357-ADB3-2C32BCF71758 @default.
- Q96115159 P356 Q96115159-5BB40910-9798-4F12-B4C3-FEEF23CE5CFB @default.
- Q96115159 P50 Q96115159-1109D28F-998A-4934-8308-7D7820BB2B50 @default.
- Q96115159 P50 Q96115159-68A41677-0AE6-4D0C-BF86-53313967A7D2 @default.
- Q96115159 P50 Q96115159-B8DB0EB0-493D-441B-9DFF-F3A08387A30F @default.
- Q96115159 P50 Q96115159-F5FBB384-2799-4C88-A3E6-5D566EA42AA2 @default.
- Q96115159 P577 Q96115159-D671F35A-A2ED-46A0-AF42-589D2D44C1AA @default.
- Q96115159 P698 Q96115159-8096D9F8-3F4B-4BB2-81AC-4FEDEE6C914F @default.
- Q96115159 P356 HON.2756 @default.
- Q96115159 P698 32495951 @default.
- Q96115159 P1433 Q15762617 @default.
- Q96115159 P1476 "Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher-risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic Syndromes" @default.
- Q96115159 P2093 "Aekaterini Megalakaki" @default.
- Q96115159 P2093 "Alexandra Kourakli" @default.
- Q96115159 P2093 "Anthi Bouchla" @default.
- Q96115159 P2093 "Argiris Symeonidis" @default.
- Q96115159 P2093 "Athanasios G Galanopoulos" @default.
- Q96115159 P2093 "Dimitris Τsokanas" @default.
- Q96115159 P2093 "Eleftheria Hatzimichael" @default.
- Q96115159 P2093 "George Dryllis" @default.
- Q96115159 P2093 "George Vrachiolias" @default.
- Q96115159 P2093 "Helen A Papadaki" @default.
- Q96115159 P2093 "Konstantinos Liapis" @default.
- Q96115159 P2093 "Maria Papaioannou" @default.
- Q96115159 P2093 "Menelaos Papoutselis" @default.
- Q96115159 P2093 "Nora-Athina Viniou" @default.
- Q96115159 P2093 "Panagiotis Zikos" @default.
- Q96115159 P2093 "Panayiotis Panayiotidis" @default.
- Q96115159 P2093 "Theodoros P Vassilakopoulos" @default.
- Q96115159 P2093 "Vasileios Papadopoulos" @default.
- Q96115159 P2860 Q24563021 @default.
- Q96115159 P2860 Q27861048 @default.
- Q96115159 P2860 Q28082460 @default.
- Q96115159 P2860 Q28283836 @default.
- Q96115159 P2860 Q33405470 @default.
- Q96115159 P2860 Q33408130 @default.
- Q96115159 P2860 Q34128471 @default.